Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01648283 · ClinicalTrials.gov registry record · NA
CYP2B6 Polymorphisms in Methadone Disposition
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT01648283 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 78 participants.
The verdict
NCT01648283, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes methadone.
Interventions
- DRUG IV racemic methadone HCl
- DRUG Oral racemic methadone HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01648283
The ClinicalTrials.gov registry entry for NCT01648283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IV racemic methadone HCl is the first listed.
NCT01648283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01648283 about?
NCT01648283 is a clinical study titled "CYP2B6 Polymorphisms in Methadone Disposition". This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes methadone.
What is the current status of trial NCT01648283?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2012-11. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01648283?
The interventions under investigation include: IV racemic methadone HCl (DRUG), Oral racemic methadone HCl (DRUG).
Who is sponsoring clinical trial NCT01648283?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.